SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Labwire Inc.

01 Jan 2009 02:01 PM
25 Nov 2008 01:46 PM
04 Nov 2008 11:20 AM
24 Sep 2008 11:15 PM
13 Sep 2008 01:53 PM <--
12 Sep 2008 12:33 AM
10 Sep 2008 12:05 AM
14 Aug 2008 11:54 PM
07 Aug 2008 08:42 PM
17 Jul 2008 11:49 PM
24 Jun 2008 11:01 PM
18 Jun 2008 11:44 PM
17 Jun 2008 07:52 PM
16 Jun 2008 07:12 PM
14 Jun 2008 01:42 PM
12 Jun 2008 10:55 PM
11 Jun 2008 10:50 PM
10 Jun 2008 12:26 AM
09 Jun 2008 11:43 PM
08 Jun 2008 08:10 PM
07 Jun 2008 07:31 PM
06 Jun 2008 08:39 PM
05 Jun 2008 12:56 AM
17 May 2008 12:58 AM
27 Apr 2008 03:53 PM
14 Dec 2006 03:01 PM
07 Dec 2006 01:48 PM
16 Jun 2006 11:54 AM
13 Jun 2006 12:44 PM
18 May 2006 11:32 AM
10 May 2006 10:45 AM
08 May 2006 06:22 PM
03 May 2006 12:30 PM
27 Apr 2006 05:10 PM
25 Apr 2006 04:27 PM
24 Apr 2006 11:45 PM
23 Apr 2006 10:25 PM
14 Apr 2006 03:48 PM
21 Mar 2006 11:22 PM
18 Mar 2006 11:30 PM
16 Mar 2006 05:34 PM

Return to Labwire Inc.
 
#subject-56492


14133 Memorial Drive #1
Houston, TX 77079
(281) 597-1611

Labwire's 19 point checklist for 2008 - Message 24931548

About Labwire, Inc.
Labwire Inc.was incorporated on October 8, 2004 as a Nevada corporation and is headquartered in Houston, Texas. It provides secure and compliant customized full service drug and alcohol testing and other employment screening including billing, customized reports, collection site identification and management, Medical Review Officer (MRO) services, education, client support systems, background checks, physicals, K-9 surveillance and more to Fortune 500 corporations via the Labwire™ Platform. Labwire™ is a proprietary, web-based application that streamlines the complex regulatory and record management activities associated with employee screening, delivering accurate timely results while eliminating service calls and paper trails. This comprehensive solution to managing employee screening services is the most efficient and cost-effective platform in the industry.

Not just another database, Labwire™ was developed by our team of industry leaders to deliver comprehensive and secure employer information management services over the Internet. Labwire’s Network Administrator previously worked alongside with the federal government in writing the HIPPA law. At the same time we provide the most comprehensive time-saving workflow automation system on the market.

The Labwire operating platform, which provides modular delivery systems, procedures compliant with HIPAA protocols (unique within the industry), and live user-friendly access to all clients, all while adhering to ISO 9000:2000 certification standards (also unique within the industry).

For more information see 8-k filings.

Officers and Directors and Key Employees

CEO G. Dexter Morris    - Message 24648964
VP Charles E. Munson - Message 24652453
VP Gary Butler - Message 24657438
Director John S. Maring - Message 24662172
K9 Services Eric Linden - Message 24668515

The Labwire management team is made up of experienced personnel along with two senior client service directors. The core management team managed the sale of over $110 million in drug testing, backgrounds, and related services before forming Labwire, Inc. and taking advantage of their experience and expertise, including their in depth knowledge of the required Department of Transportation (“DOT”) testing regulations (49 CFR, Part 40). As a result of these efforts, Labwire: (1) enables clients to effectively manage drug testing programs over the Internet; (2) provides clients with secure and centralized, collection and analysis of highly confidential data produced by drug testing; and (3) allows for Web-enabled access to individual test results and other detailed compliance reports. These revenues account for approximately 60% of Labwire’s revenues. Through the implementation of Labwire’s technology, the Company anticipates evolving from a traditional TPA service provider to a leading substance abuse program application service provider (“ASP”).

Services

Message 24684032

Principal Suppliers and Partners

Message 24703144

Strategic Acquisitions

Occupational Testing, Inc. - Message 24675881
Occupational Testing Website - occtesting.com

Alliance Agreements

Labwire Signs Alliance Agreement With USIS - Message 24680636
USIS Website - usis.com

Labwire Signs Alliance with Global Medical Testing - Message 24768919


Current News ~~~~> finance.yahoo.com
Historical News ~> labwire.com
Company Website ~> labwire.com
SEC EDGAR ~~~~~~~> sec.gov

Description of Securities

Common Stock

We are authorized by our Certificate of Incorporation to issue an aggregate of One Hundred Fifty Million (150,000,000) shares of capital stock, of which all are shares of Common Stock, par value of $0.001 per share (the “Common Stock”).

Preferred Stock

Our Articles of Incorporation do not authorize the issuance of Preferred Stock. There are presently no shares of preferred stock outstanding.

The Company has not effectuated a change of control, or an increase in its authorized common stock. There are no past, pending or anticipated stock splits, stock dividends, recapitalizations, mergers, acquisitions, spin-off, or reorganizations.

Transfer Agent

The transfer agent and registrar for our Common Stock is Holliday Stock Transfer, Inc., 2939 N. 67th Place, Scottsdale, AZ, 85251. Phone (480) 481-3940 - Sharon.

Share Structure per T.A. - July 14, 2008
Authorized Shares: 150,000,000
Outstanding Shares: 140,899,001
Restricted Shares: 122,749,003 (120 MM Mgmt 144's)
Floating Shares: 18,149,998





Also Visit Labwire iHub - investorshub.com

**Attention** Please read - Message 24940195